Does OSIMERTINIB Cause Metastases to bone? 264 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 264 reports of Metastases to bone have been filed in association with OSIMERTINIB (TAGRISSO). This represents 1.0% of all adverse event reports for OSIMERTINIB.
264
Reports of Metastases to bone with OSIMERTINIB
1.0%
of all OSIMERTINIB reports
41
Deaths
43
Hospitalizations
How Dangerous Is Metastases to bone From OSIMERTINIB?
Of the 264 reports, 41 (15.5%) resulted in death, 43 (16.3%) required hospitalization, and 7 (2.7%) were considered life-threatening.
Is Metastases to bone Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OSIMERTINIB. However, 264 reports have been filed with the FAERS database.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Metastases to bone?
LETROZOLE (1,735)
RIBOCICLIB (1,538)
FULVESTRANT (1,525)
ZOLEDRONIC ACID (1,087)
DENOSUMAB (1,053)
TAMOXIFEN (894)
LEUPROLIDE (848)
EVEROLIMUS (845)
PACLITAXEL (820)
PALBOCICLIB (793)
Which OSIMERTINIB Alternatives Have Lower Metastases to bone Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN